Spartan Planning & Wealth Management purchased a new position in JPMorgan Chase & Co. (NYSE:JPM) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,058 shares of the financial services provider’s stock, valued at approximately $153,000. Other hedge funds have also […]
Sweetgreen (NYSE:SG – Free Report) had its target price lifted by JPMorgan Chase & Co. from $13.00 to $20.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. Other analysts have also recently issued reports about the company. Piper Sandler upped their target […]
Privia Health Group (NASDAQ:PRVA – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $38.00 to $30.00 in a research report released on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other equities analysts also recently issued reports on PRVA. Truist Financial […]
Diversified Trust Co cut its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 26.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 84,353 shares of the financial services provider’s stock after selling 30,903 shares during the period. Diversified Trust […]
JPMorgan Chase & Co. reiterated their neutral rating on shares of Diageo (LON:DGE – Free Report) in a report released on Monday morning, Marketbeat.com reports. Several other analysts have also recently commented on DGE. Royal Bank of Canada decreased their price objective on shares of Diageo from GBX 2,700 ($34.25) to GBX 2,500 ($31.71) and […]